Adı Soyadı: Tuğcan Alp Kırkızlar

Doğum Tarihi: 14 Eylül 1982

İletişim:

Mail: tugcanalp82@hotmail.com, tugcanalpkirkizlar@trakya.edu.tr

Adres: Trakya Üniversitesi Tıp Fakültesi, Hematoloji Kliniği, Balkan Yerleşkesi, 22030, Edirne

SCI-SSCI, SCI Expanded ve AHCI Kapsamındaki Yayınları

• Incidence and predisposing factors of infection in patients treated with hypomethylating agents, Leukemia Research, ALP KIRKIZLAR TUGCAN, KIRKIZLAR HAKKI ONUR, DEMIRCI UFUK, UMUT AYTUG, IFLAZOGLU HÜSEYIN, ÜMIT ELIF GÜLSÜM, DEMIR AHMET MUZAFFER, vol. 127, no. 107043, pp. 1-6, 2023 (Nisan 2023)

  3 ATIF

  ATIFLAR

  • Mathur, S., Christou, G., Delage, R. et al. Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registry. Ann Hematol 103, 5241–5248 (2024). https://doi.org/10.1007/s00277-024-06096-x (Aralık 2024)
  • Title: Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry Author(s): de Valence, B (de Valence, Benjamin); Delaune, M (Delaune, Marion); Nguyen, Y (Nguyen, Yann); Jachiet, V (Jachiet, Vincent); Heiblig, M (Heiblig, Mael); Jean, A (Jean, Alexis); Tuczkiewicz, SR (Tuczkiewicz, Stanislas Riescher); Henneton, P (Henneton, Pierrick); Guilpain, P (Guilpain, Philippe); Schleinitz, N (Schleinitz, Nicolas); Le Guenno, G (Le Guenno, Guillaume); Lobbes, H (Lobbes, Herve); Lacombe, V (Lacombe, Valentin); Ardois, S (Ardois, Samuel); Lazaro, E (Lazaro, Estibaliz); Langlois, V (Langlois, Vincent); Outh, R (Outh, Roderau); Vinit, J (Vinit, Julien); Martellosio, JP (Martellosio, Jean-Philippe); Decker, P (Decker, Paul); Moulinet, T (Moulinet, Thomas); Dieudonne, Y (Dieudonne, Yannick); Bigot, A (Bigot, Adrien); Terriou, L (Terriou, Louis); Vlakos, A (Vlakos, Alexandre); de Maleprade, B (de Maleprade, Baptiste); Denis, G (Denis, Guillaume); Broner, J (Broner, Jonathan); Kostine, M (Kostine, Marie); Humbert, S (Humbert, Sebastien); Lifermann, F (Lifermann, Francois); Samson, M (Samson, Maxime); Pechuzal, S (Pechuzal, Susann); Aouba, A (Aouba, Achille); Kosmider, O (Kosmider, Olivier); Dion, J (Dion, Jeremie); Grosleron, S (Grosleron, Sylvie); Bourguiba, R (Bourguiba, Rim); Terrier, B (Terrier, Benjamin); Georgin-Lavialle, S (Georgin-Lavialle, Sophie); Fain, O (Fain, Olivier); Mekinian, A (Mekinian, Arsene); Morgand, M (Morgand, Marjolaine); Comont, T (Comont, Thibault); Hadjadj, J (Hadjadj, Jerome) Group Author(s): French VEXAS Group Source: ANNALS OF THE RHEUMATIC DISEASES DOI: 10.1136/ard-2023-224819 Early Access Date: DEC 2023 Accession Number: WOS:001129750100001 (Aralık 2023)
  • Title: Tuberculosis-induced aplastic crisis and atypical lymphocyte expansion in advanced myelodysplastic syndrome: A case report and review of literature Author(s): Sun, XY (Sun, Xiao-Yun); Yang, XD (Yang, Xiao-Dong); Xu, J (Xu, Jia); Xiu, NN (Xiu, Nuan-Nuan); Ju, B (Ju, Bo); Zhao, XC (Zhao, Xi-Chen) Source: WORLD JOURNAL OF CLINICAL CASES Volume: 11 Issue: 19 Pages: 4713-4722 DOI: 10.12998/wjcc.v11.i19.4713 Published: JUL 6 2023 Accession Number: WOS:001032687700025 (Temmuz 2023)

• The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study (Şubat 2022) s00277-022-04798-8.pdf

  1 ATIF

  ATIFLAR

  • Title: Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWG Author(s): Kungwankiattichai, S (Kungwankiattichai, Smith); Owattanapanich, W (Owattanapanich, Weerapat); Rattanathammethee, T (Rattanathammethee, Thanawat); Rattarittamrong, E (Rattarittamrong, Ekarat); Chanswangphuwana, C (Chanswangphuwana, Chantiya); Polprasert, C (Polprasert, Chantana); Limvorapitak, W (Limvorapitak, Wasithep); Saengboon, S (Saengboon, Supawee); Niparuck, P (Niparuck, Pimjai); Puavilai, T (Puavilai, Teeraya); Julamanee, J (Julamanee, Jakrawadee); Saelue, P (Saelue, Pirun); Wanitpongpun, C (Wanitpongpun, Chinadol); Prayongratana, K (Prayongratana, Kannadit); Sriswasdi, C (Sriswasdi, Chantarapa); Nakhakes, C (Nakhakes, Chajchawan) Source: HEMATOLOGY Volume: 28 Issue: 1 Article Number: 2191462 DOI: 10.1080/16078454.2023.2191462 Published: DEC 31 2023 Accession Number: WOS:000955185100001 (Aralık 2023)

• BAYSAL MEHMET, GÜRSOY VILDAN, HUNUTLU FAZIL ÇAGRI, ERKAN ÖZMARASALI BUKET, DEMIRCI UFUK, BAS VOLKAN, KARAMAN GÜLSARAN SEDANUR, PINAR IBRAHIM ETHEM, ERSAL TUBA, ALP KIRKIZLAR TUGCAN, ATLI EMINE IKBAL, KIRKIZLAR HAKKI ONUR, ÜMIT ELIF GÜLSÜM, GÜRKAN HAKAN, ÖZKOCAMAN VILDAN, ÖZKALEMKAS FAHIR, DEMIR AHMET MUZAFFER, ALI RIDVAN, The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study, Annals of Hematology, vol. 101, pp. 1049-1057, 2022

• Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia (Ekim 2020) LR VRE.pdf

  6 ATIF

  ATIFLAR

  • Characteristics of Enterococcus species bloodstream infections among adults with and without onco-hematological malignancies: Experiences from the national center of Hungary https://doi.org/10.1556/1886.2024.00011 European Journal of Microbiology and Immunology Volume/Issue: Volume 14: Issue 2 (Mayıs 2024)
  • Title: Epidemiology and outcomes of vancomycin-resistant enterococcus infections: a systematic review and meta-analysis Author(s): Eichel, VM (Eichel, V. M.); Last, K (Last, K.); Brühwasser, C (Bruhwasser, C.); von Baum, H (von Baum, H.); Dettenkofer, M (Dettenkofer, M.); Göetting, T (Gotting, T.); Grundmann, H (Grundmann, H.); Güeldenhöeven, H (Guldenhoven, H.); Liese, J (Liese, J.); Martin, M (Martin, M.); Papan, C (Papan, C.); Sadaghiani, C (Sadaghiani, C.); Wendt, C (Wendt, C.); Werner, G (Werner, G.); Mutters, NT (Mutters, N. T.) Source: JOURNAL OF HOSPITAL INFECTION Volume: 141 Pages: 119-128 DOI: 10.1016/j.jhin.2023.09.008 Early Access Date: OCT 2023 Published: NOV 2023 Accession Number: WOS:001100032800001 (Kasım 2023)
  • Title: Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study Author(s): Meschiari, M (Meschiari, Marianna); Kaleci, S (Kaleci, Shaniko); Del Monte, M (Del Monte, Martina); Dessilani, A (Dessilani, Andrea); Santoro, A (Santoro, Antonella); Scialpi, F (Scialpi, Francesco); Franceschini, E (Franceschini, Erica); Orlando, G (Orlando, Gabriella); Cervo, A (Cervo, Adriana); Monica, M (Monica, Morselli); Forghieri, F (Forghieri, Fabio); Venturelli, C (Venturelli, Claudia); Ricchizzi, E (Ricchizzi, Enrico); Chester, J (Chester, Johanna); Sarti, M (Sarti, Mario); Guaraldi, G (Guaraldi, Giovanni); Luppi, M (Luppi, Mario); Mussini, C (Mussini, Cristina) Source: ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL Volume: 12 Issue: 1 Article Number: 126 DOI: 10.1186/s13756-023-01332-x Published: NOV 13 2023 Accession Number: WOS:001101622600001 (Kasım 2023)
  • Title: Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models Author(s): Danielsen, AS (Danielsen, Anders Skyrud); Franconeri, L (Franconeri, Lea); Page, S (Page, Samantha); Myhre, AE (Myhre, Anders Eivind); Tornes, RA (Tornes, Ragnhild Agathe); Kacelnik, O (Kacelnik, Oliver); Bjornholt, JV (Bjornholt, Jorgen Vildershoj) Source: BMC INFECTIOUS DISEASES Volume: 23 Issue: 1 Article Number: 247 DOI: 10.1186/s12879-023-08182-3 Published: APR 18 2023 Accession Number: WOS:000974817800012 (Nisan 2023)
  • Cachectic muscle wasting in acute myeloid leukaemia: a sleeping giant with dire clinical consequences (Aralık 2021)
  • Prevalence of Vancomycin-Resistant Enterococci and Antimicrobial Residues in Wastewater and Surface Water (Aralık 2021)

• The Incidence of Venous Thromboembolism and Impact on Survival in Hodgkin Lymphoma (Mart 2020) CLML HL.pdf

  10 ATIF

  ATIFLAR

  • Venous Thromboembolism Post-allogeneic Hematopoietic Cell Transplant: Risk Factors, Incidence, and Outcomes. THROMBOSIS AND HAEMOSTASIS DOI10.1055/a-2365-8883 (Temmuz 2024)
  • Platelet Parameters as Biomarkers for Thrombosis Risk in Cancer: A Systematic Review and Meta-analysis. SEMINARS IN THROMBOSIS AND HEMOSTASIS Volume50Issue03Page360-383 DOI10.1055/s-0043-1764381 (Nisan 2024)
  • Novel Insights in Venous Thromboembolism Risk Assessment Methods in Ambulatory Cancer Patients: From the Guidelines to Clinical Practice. CANCERS Volume16Issue2 DOI10.3390/cancers16020458 (Ocak 2024)
  • The Application of Existing Risk Assessment Models (RAMS) to Predict the Occurrence of Venous Thromboembolic Events among Patients with Classic Hodgkin Lymphoma. JOURNAL OF CLINICAL MEDICINE Volume13Issue2 DOI10.3390/jcm13020436 (Ocak 2024)
  • Prevalence of and Risk Factors for Venous Thromboembolism in Patients With Lymphoma: A Meta-Analysis. ONCOLOGY NURSING FORUM Volume51Issue1Page59-69 DOI10.1188/24.ONF.59-69 (Ocak 2024)
  • Title: Platelet Parameters as Biomarkers for Thrombosis Risk in Cancer: A Systematic Review and Meta-analysis Author(s): Malte, AL (Malte, Anne Lind); Hojbjerg, JA (Hojbjerg, Johanne Andersen); Larsen, JB (Larsen, Julie Brogaard) Source: SEMINARS IN THROMBOSIS AND HEMOSTASIS DOI: 10.1055/s-0043-1764381 Early Access Date: MAR 2023 Accession Number: WOS:000952319800001 (Mart 2023)
  • Title: Map of thrombogenesis in viral infections and viral-driven tumours Author(s): Neto, BV (Neto, Beatriz Vieira); Tavares, V (Tavares, Valeria); Santos, JMO (Santos, Joana M. O.); Cerqueira, F (Cerqueira, Fatima); Pereira, D (Pereira, Deolinda); Medeiros, R (Medeiros, Rui) Source: DISCOVER ONCOLOGY Volume: 14 Issue: 1 DOI: 10.1007/s12672-022-00610-1 Published: JAN 8 2023 Accession Number: WOS:000912865700001 (Ocak 2023)
  • Cancer-Associated Thrombosis: A Clinical Scoping Review of the Risk Assessment Models Across Solid Tumours and Haematological Malignancies (Temmuz 2021)
  • Risk Assessment Models for Thrombosis and Anticoagulant-Related Bleeding in Ambulatory Cancer Patients (Ocak 2021)
  • A rare complication in a child undergoing chemotherapy for Hodgkin lymphoma - multiple cerebral venous sinus thrombosis (Ocak 2021)

• KIRKIZLAR HAKKI ONUR, ALP KIRKIZLAR TUGCAN, ÜMIT ELIF GÜLSÜM, ASKER ISMAIL, BAYSAL MEHMET, BAS VOLKAN, KARAMAN GÜLSARAN SEDANUR, DEMIRCI UFUK, DEMIR AHMET MUZAFFER, The Incidence of Venous Thromboembolism and Impact on Survival in Hodgkin Lymphoma, CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol. 20, no. 8, pp. 542-547, 2020

• ALP KIRKIZLAR TUGCAN, AKALIN EMIN HALIS, KIRKIZLAR HAKKI ONUR, ÖZKALEMKAS FAHIR, ÖZKOCAMAN VILDAN, KAZAK ESRA, ÖZAKIN CÜNEYT, BÜLBÜL ESRA NUR, ÖZBOZ EZGI SEZEN, ALI RIDVAN, Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia, LEUKEMIA RESEARCH, vol. 99, no. 106463, pp. 1-5, 2020

• B. Koc, F. Tutal, M. Urumdas, Y. Ozkurt, T. Erus, A. Yavuz, O. Kemik, The Preliminary Experience in the Emergency Department of a Newly Opened Penitentiary Institution Hospital in Turkey, 10.4103/1947-2714.141642, NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, vol. 6, no. 9, pp. 460-465, 2014

• C. Meral, M. Aktuglu, H. Hassoy, Z. Karaali, T. Alioglu, O. Kirkizlar, S. Acar, M. Kendir, S. Erez, T. Erus, S. Sayilan, The Relationship Between Factor VIII and Coronary Artery Diseases, 10.4274/Haseki.726, HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, vol. 50, no. 4, pp. 113-118, 2012

Uluslararası Hakemli Dergilerde Yayınlanan Makaleler

• Venetoclax is a drug commonly associated with tumor lysis syndrome (TLS) and electrolyte imbalances. However, its effects on electrolyte metabolism are not limited to TLS. We present a patient with relapsed chronic lymphocytic leukemia who experienced electrolyte imbalances as grade 2 hypocalcemia, hypophosphatemia, and hypomagnesemia during the venetoclax escalation period, independent of TLS or renal or gastrointestinal loss. The patient was successfully managed with close electrolyte monitoring and appropriate electrolyte replacement without discontinuing venetoclax. There is limited data on electrolyte imbalances associated with venetoclax other than TLS. Studies show the incidence and severity of electrolyte imbalances, but managing these adverse events is not clear enough. Therefore, we would like to share our approach and experience with a patient who developed venetoclax-induced hypocalcemia, hypophosphatemia, and hypomagnesemia. https://doi.org/10.46310/tjim.1494510 (Ekim 2024)

• Evaluation of leukapheresis and leukapheresis with additional cytoreduction in acute leukemia with hyperleukocytosis, ALP KIRKIZLAR TUGCAN, DEMIR AHMET MUZAFFER, Turkish Journal of Internal Medicine, vol. 5, no. 3, pp. 191-198, 2023 (Temmuz 2023)

• Comparison of Hemophagocytic Lymphohistiocytosis Diagnostic Criteria in Malignancy-Associated Hemophagocytic Lymphohistiocytosis Patients (Aralık 2022) 10.46310-tjim.1121064-2446228.pdf

• The incidence of osteoporosis and vertebral fracture in women with postmenopausal type 2 diabetes mellitus and predisposing factors of vertebral fractures (Temmuz 2021) The_incidence_of_osteoporosis_and_vertebral_fractu.pdf

  1 ATIF

  ATIFLAR

  • Journal of Cardiovascular Disease Research Osteoporosis in Diabetics-A observational study in Kashmiri population Journal of Cardiovascular Disease Research ISSN: 0975-3583, 0976-2833 VOL14, ISSUE 09, 2023 (Aralık 2023)

• ALP KIRKIZLAR TUGCAN, AKTUGLU MEHMET BURAK, The incidence of osteoporosis and vertebral fracture in women with postmenopausal type 2 diabetes mellitus and predisposing factors of vertebral fractures, The International Journal of Advances in Medicine, vol. 8, no. 10, pp. 1478-1482, 2021

Uluslararası Bilimsel Toplantılarda Sunulan ve Bildiri Kitabında Basılan Bildiriler (Proceedings)

• THE INCIDENCE OF INFECTIONS AND ITS EFFECTS ON MORTALITY IN AML PATIENTS TREATED WITH VENETOCLAX. P2219. AVRUPA HEMATOLOJİ KONGRESİ 2024 (Haziran 2024)

• P977: THE VENOUS THROMBOEMBOLISM RISK ASSESMENT MODELS IN MULTIPLE MYELOMA Alp Kirkizlar, Tugcan1; Kirkizlar, Onur1; Muzaffer Demir, Ahmet1; Gulsum Umit, Elif1 Author Information HemaSphere 7(S3):p e2045172, August 2023. | DOI: 10.1097/01.HS9.0000970812.20451.72 (Ağustos 2023) p977__the_venous_thromboembolism_risk_assesment.877.pdf

• O-11: Evaluation of Indications, Complications, Outcomes and Hospital Mortality of TPE Applied Patients (Eylül 2022) waa2022_program_abstract_book.pdf

• V. Ozkocaman, F. Ozkalemkas, R. Ali, Y. Karacan, T. Ersal, H. Gozden, T. Erus, E. Kazak, H. Akalin, Oral Valganciclovir As Preemptive Therapy for Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients, BLOOD, vol. 124, no. 21, pp. , 2014 (Aralık 2014)

  1 ATIF

  ATIFLAR

  • Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring (Aralık 2020)

Ulusal Hakemli Dergilerde Yayınlanan Makaleler

• Özet: Ortanca tanı yaşı 68 olan akut myeloid lösemide (AML) intensif tedavi adayı olamayan ileri yaş grubunda sağkalım süresi belirgin olarak düşüktür. Günümüzde bu hasta grubu için standart tedavi haline gelen hipometilleyici ajan-venetoklaks (HMA-V) kombinasyonuyla sağkalım süresi ve yaşam kalitesi artmıştır. Biz de merkezimizde intensif tedaviye uygun olmayan AML hasta grubunda HMA-V kombinasyon tedavisi sonuçlarını incelemeyi amaçladık. Çalışmaya dahil edilen 37 hastanın ortanca yaşı 70.2 yıl ve %51.4’ ü kadın idi. Hastaların %73’ü de novo lösemi olup 4 hasta nüks, 1 hasta azasitidin sonrası refrakter hastalıktı. Remisyon sağlanan 2 hastaya intensif tedavi intoleransı/yan etkisi nedeniyle HMA-V kombinasyonu verildi. Azasitidin kullanım oranı %78.6 idi. Ortanca kurs sayısı 3 idi. 1. veya 2. kurs sonunda kemik iliği değerlendirmesinde remisyon oranı %51.4 olarak bulundu. Ortalama izlem süresi 11.9 ay olup hastaların %56.75’i hayatını kaybetti. Sağkalım analizlerinde ortalama ve ortanca yaşam süreleri 18 ve 13 ay olarak saptandı. Ortalama yaşam süreleri remisyon sağlananlarda, sağlanamayanlarda ve değerlendirilemeyenlerde sırasıyla 27.1, 4.1 ay ve ve 7.5 ay idi ve gruplar arasında anlamlı farklılık saptandı (p <0.001). Azasitidin ile ortalama ve ortanca yaşam süreleri 22.03 ve 23 ay iken, desitabin ile bu süreler sırasıyla 3.87 ve 3 ay idi ve belirgin istatiksel farklılık mevcuttu (p <0.001). Cox regresyon multivariate analizinde mortalite üzerinde etkili tek faktör 1./2. siklus sonu değerlendirmesinde remisyonda olmamak olarak bulundu (p 0.004). Sonuç olarak, merkezimizin sağkalım ve remisyon oranları gerçek yaşam çalışmalarıyla benzer olarak bulunmuştur. Anahtar Kelimeler: Akut Myeloid Lösemi, Azasitidin, Desitabin, Venetoklaks https://doi.org/10.20515/otd.1436206 (Şubat 2024)

• Ekstranodal Baş Boyun Diffüz Büyük B Hücreli Lenfomalarının Geriye Yönelik Olarak Değerlendirilmesi ve Nodal Hastalık ile Karşılaştırılması (Ekim 2021) llm DBBHL.pdf

• KIRKIZLAR HAKKI ONUR, ALP KIRKIZLAR TUGCAN, DEMIRCI UFUK, KARAMAN GÜLSARAN SEDANUR, BAS VOLKAN, ÜMIT ELIF GÜLSÜM, DEMIR AHMET MUZAFFER, Ekstranodal Bas Boyun Diffüz Büyük B Hücreli Lenfomalarinin Geriye Yönelik Olarak Degerlendirilmesi ve Nodal Hastalik ile Karsilastirilmasi, LLM Dergi, vol. 5, no. 2, pp. 21-26, 2021

• ALP KIRKIZLAR TUGCAN, ÇALAPKULU MURAT, GÖMLEKSIZ MUHAMMET RIDVAN, ÖZKALEMKAS FAHIR, ÖZKOCAMAN VILDAN, ALI RIDVAN, TÜZÜNER TUNÇAY NURIYE NUKHET, Case Report of a Rare Disease: Kimura Disease, Turkiye Klinikleri, vol. 3, no. 1, pp. 39-42, 2018

Ulusal Bilimsel Toplantılarda Sunulan ve Bildiri Kitabında Basılan Bildiriler

• TRAKYA üNİVERSİTESİ KAN MERKEZİ 5 YILLIK HEMOVİJİLANS VERİLERİ. TP-22/361. 50. ULUSAL HEMATOLOJİ KONGRESİ (Kasım 2024)

• SS-37 Referans Numarası: 154 YENİ TANILI ERİŞKİN AKUT MİYELOİD LÖSEMİLİ HASTALARDA HÜCRE PROLİFERASYONU, HÜCRE FARKLILAŞMASI VE APOPİTOZİS ÜZERİNE ETKİLİ UZUN KODLAMAYAN RNA’LARIN ARAŞTIRILMASI Ebru Göncü4, Hakkı Onur Kırkızlar2, Hakan Gürkan1, Tuğcan Alp Kırkızlar2, Elif Gülsüm Ümit2, Ahmet Muzaffer Demir2, Jülide Tozkır3 50. ULUSAL HEMATOLOJİ KONGRESİ (Kasım 2024)

• Multiple Miyelom Tanılı Hastalarda Tedavideki Yeni Yaklaşımlar Sonrası Yaşam Kalitesinin Qly-30 Ve Myc-20 Kriterlerine Göre Değerlendirilmesi (Kasım 2023) ulusal 2023 tum-kitap-icin-tiklayiniz.pdf

Ulusal Konferans ve Sempozyumlar

• SS-30 Referans Numarası: 352 AML’DE HMA VENETOKLAKS KOMBİNASYONUNDA ANTİFUNGAL PROFİLAKSİ VE VENETOKLAKS KULLANIMI- THD HEMATOLOJİDE ENFEKSİYONLAR VE DESTEK TEDAVİLER ALT KOMİTESİ ANKET ÇALIŞMASI Tuğcan Alp Kırkızlar1, Vildan Özkocaman2 Türk Hematoloji Derneği 50. Ulusal Hematoloji Kongresi 2024 (Kasım 2024)

• S21- ERİŞKİN AKUT LENFOBLASTİK LÖSEMİDE SAĞKALIMA ETKİ EDEN FAKTÖRLER Tuğcan Alp Kırkızlar1 EHOK 2024 Sözlü Sunum (Mart 2024)

Yazılan Ulusal Kitaplar veya Kitaplarda Bölümler

• TIP HEKİMİNİN SON TEKRARLARI Editörler:TABAKOĞLU ERHAN, GÜDÜCÜOĞLU HÜSEYİN, PARLAK MEHMET ISSN:978-975-374-370-9 Talasemiler (Ocak 2024)

• TIP HEKİMİNİN SON TEKRARLARI Editörler:TABAKOĞLU ERHAN, GÜDÜCÜOĞLU HÜSEYİN, PARLAK MEHMET ISSN:978-975-374-370-9 Demir Eksikliği Anemisi (Ocak 2024)

• Klinik pratikte hematolojik hastalıklara yaklaşım, Kan transfüzyonu endikasyonları ve komplikasyonlar ISBN: 978-605-9665-67-4 (Aralık 2021)

Üye Olunan Kurum ve Kuruluşlar

• Edirne klinik araştırmalar etik kurul üyeliği

Editörlük / Yayınlama

• BALKAN MEDICAL JOURNAL EDITORIAL BOARD MEMBER 2024 (Aralık 2024)

Yapılan Hakemlikler

• OPTIMIZING AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTPLE MYELOMA BALKAN MED J-2024-11-132 (Aralık 2024)

• POSACONAZOLE THERAPEUTIC DRUG MONITORING IN DAILY PRACTICE-TJH-2024-0458 (Aralık 2024)

• EVALUATION OF THE EFFECTS OF REGULATORY T CELLS ON SURVIVAL OUTCOMES IN PATIENTS WITH ACUTE LEUKEMIA WHO DEVELOPED FEBRILE NEUTROPENIA TJMED-2024-01962 (Ekim 2024)

• Pre-publication review Canonical URL: https://publons.com/wos-op/review/author/3ACdqi4N/ Code: 3ACdqi4N Performed for: Clinical Medicine Insights: Oncology (journal) Verification: YES. Verified by journal integration Date Date of review: 2024 (Temmuz 2024)

• Review date: 2024 Type: reviewRole: reviewer Show less detailView Review identifier(s) SOURCE-WORK-ID: f500494f-c95a-441c-9a28-e63817e5b7ad Convening organization Elsevier, Inc. (New York, US) Source : Elsevier Editorial (Haziran 2024)

• Review date: 2024 Type: reviewRole: reviewer Show less detailView Review identifier(s) SOURCE-WORK-ID: 3ccb814a-f96b-4f1c-9f8a-83006f4e35e8 Convening organization Elsevier, Inc. (New York, US) Source : Elsevier Editorial (Haziran 2024)

• Review date: 2024 Type: reviewRole: reviewer Show less detailView Review identifier(s) SOURCE-WORK-ID: 304ca6b8-549b-47e4-8ab0-2d72c6d4b78a Convening organization Elsevier, Inc. (New York, US) Source : Elsevier Editorial (Mayıs 2024)

• THE IMPORTANCE OF TP53 STATUS IN CART THERAPHY:THE EXAMPLE OF CLL. LEUKEMİA RESEARCH. NOV 2023 (Kasım 2023)

• THE IMPACT OF VENETOCLAX ON EARLY MORTALITY IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA SEP 2023 LEUKEMIA RESEARCH (Eylül 2023)

• SINGLE CENTER RETROSPECTIVE ANALYSES OF EXTRACORPOREAL PHOTOPHERESIS THERAPHY IN PATIENTS HEAVILY PRETREATED FOR CHRONIC GVHD WITH STEROID FAILURE. LEUKEMIA RESEARCH. SEP 2023 (Eylül 2023)

• AML WITH CEBPA MUTATIONS: A COMPARISION OF ICC AND WHO HAEM5 CRITERIA IN PATIENTS WITH>%20 BLASTS. LEUKEMIA RESEARCH AGU 2023 (Ağustos 2023)

• MYC Overexpression is Associated with an Early Disease Progression from MDS to AML LR-D-21-00468R1 (Ekim 2021) My Review History.html

• Clinicopathological characteristics and possible prognostic factors of lymphoepithelioid cell lymphoma (Lennert lymphoma) LR-D-21-00273 (Mayıs 2021) My Review History.html

Diğer

• WEB OF SCIENCE H INDEX 3 (Aralık 2024)

• ALP KIRKIZLAR TUGCAN, KIRKIZLAR HAKKI ONUR, Iç Hastaliklari 2 Cilt, 4. Baski, Günes Kitapevi, Ankara-TÜRKIYE PROLENFOSİTİK LÖSEMİ BÖLÜMÜ (Ocak 2024)

• ALP KIRKIZLAR TUGCAN, KIRKIZLAR HAKKI ONUR, Iç Hastaliklari 2 Cilt, 4. Baski, Günes Kitapevi, Ankara-TÜRKIYE

• H İNDEX 3 PUAN (Ocak 2023)

• H İNDEKSİ 2 PUAN

• T. Alp, V. Ozkocaman, F. Ozkalemkas, C. Sanli, H. Gozden, Z. Yegen, R. Ali, A CASE OF AN ANTITHROMBIN DEFICIENCY WITH MESENTERIC THROMBOSES AND CEREBRAL INFARCT, THROMBOSIS RESEARCH, vol. 141, pp. S76-S76, 2016

• V. Ozkocaman, F. Ozkalemkas, B. Cilo, T. Alp, T. Ersal, E. Gozden, Z. Yegen, A. Ridvan, B. Ener, Invasive Fusariosis in Patients with Hematologic Malignancies at a University Hospital, BLOOD, vol. 126, no. 23, pp. , 2015